REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017

Feb 11, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2016-12-31

Reporting Person: YANCOPOULOS GEORGE (Director, President & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-20	Common Stock	G	1105	$0.0	Disposed	66871	Indirect
2016-12-20	Common Stock	G	1071	$0.0	Disposed	65800	Indirect
2016-12-20	Common Stock	G	670	$0.0	Disposed	65130	Indirect
2016-12-20	Common Stock	G	536	$0.0	Disposed	64594	Indirect
2016-12-20	Common Stock	G	536	$0.0	Disposed	64058	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	591348	Direct
Common Stock	500000	Indirect
Common Stock	5676	Indirect